SAXO5
gene geneOn this page
Also known as FLJ35784
Summary
SAXO5 (stabilizer of axonemal microtubules 5, HGNC:24745) is a protein-coding gene on chromosome 19p13.2, encoding Stabilizer of axonemal microtubules 5 (Q8NA69).
At a glance
- GWAS associations: 20
- Clinical variants (ClinVar): 14 total
- MANE Select transcript:
NM_198534
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24745 |
| Approved symbol | SAXO5 |
| Name | stabilizer of axonemal microtubules 5 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ35784 |
| Ensembl gene | ENSG00000198723 |
| Ensembl biotype | protein_coding |
| Entrez | 374877 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 4 protein_coding, 2 retained_intron, 1 nonsense_mediated_decay
ENST00000361664, ENST00000596132, ENST00000596524, ENST00000597207, ENST00000600112, ENST00000601176, ENST00000601292
RefSeq mRNA: 1 — MANE Select: NM_198534
NM_198534
CCDS: CCDS12179
Canonical transcript exons
ENST00000361664 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001053200 | 7507056 | 7507141 |
| ENSE00001053210 | 7505964 | 7506165 |
| ENSE00001202660 | 7508206 | 7508450 |
| ENSE00001270397 | 7497548 | 7497682 |
| ENSE00001635576 | 7504121 | 7504224 |
| ENSE00001673820 | 7505324 | 7505436 |
| ENSE00001688997 | 7504311 | 7504411 |
| ENSE00001762410 | 7505517 | 7505626 |
| ENSE00003794673 | 7500806 | 7501399 |
Expression profiles
Bgee: expression breadth ubiquitous, 154 present calls, max score 87.64.
FANTOM5 (CAGE): breadth broad, TPM avg 0.5775 / max 55.0324, expressed in 218 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 173550 | 0.2178 | 93 |
| 173549 | 0.0859 | 22 |
| 173552 | 0.0832 | 26 |
| 173551 | 0.0626 | 21 |
| 173548 | 0.0611 | 19 |
| 173546 | 0.0291 | 4 |
| 173545 | 0.0252 | 3 |
| 173547 | 0.0126 | 7 |
Top tissues by expression
251 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 87.64 | gold quality |
| left testis | UBERON:0004533 | 87.31 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 87.11 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 86.48 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.94 | gold quality |
| testis | UBERON:0000473 | 84.68 | gold quality |
| sperm | CL:0000019 | 84.23 | silver quality |
| nasal cavity epithelium | UBERON:0005384 | 83.12 | gold quality |
| kidney epithelium | UBERON:0004819 | 81.95 | gold quality |
| pancreatic ductal cell | CL:0002079 | 81.06 | silver quality |
| myocardium | UBERON:0002349 | 78.79 | gold quality |
| right adrenal gland | UBERON:0001233 | 77.64 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 77.57 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 77.25 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 76.54 | gold quality |
| left adrenal gland | UBERON:0001234 | 76.28 | gold quality |
| pituitary gland | UBERON:0000007 | 75.67 | gold quality |
| adrenal cortex | UBERON:0001235 | 75.54 | gold quality |
| parotid gland | UBERON:0001831 | 75.31 | gold quality |
| adenohypophysis | UBERON:0002196 | 73.98 | gold quality |
| adrenal gland | UBERON:0002369 | 72.30 | gold quality |
| vastus lateralis | UBERON:0001379 | 71.95 | gold quality |
| quadriceps femoris | UBERON:0001377 | 71.87 | gold quality |
| adult organism | UBERON:0007023 | 71.74 | silver quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 69.78 | gold quality |
| substantia nigra | UBERON:0002038 | 69.66 | gold quality |
| heart right ventricle | UBERON:0002080 | 69.51 | gold quality |
| spinal cord | UBERON:0002240 | 68.89 | gold quality |
| putamen | UBERON:0001874 | 68.73 | gold quality |
| midbrain | UBERON:0001891 | 68.58 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.36 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Saxo5 | ENSMUSG00000040340 |
| rattus_norvegicus | Saxo5 | ENSRNOG00000000973 |
Protein
Protein identifiers
Stabilizer of axonemal microtubules 5 — Q8NA69 (reviewed: Q8NA69)
Alternative names: Testis-expressed protein 45
All UniProt accessions (5): Q8NA69, M0QY34, M0QYK1, M0R096, M0R0L7
UniProt curated annotations — full annotation on UniProt →
Tissue specificity. Highly expressed in testis.
RefSeq proteins (1): NP_940936* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR028001 | SAXO5 | Family |
Pfam: PF15373
UniProt features (12 total): region of interest 5, sequence variant 5, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NA69-F1 | 54.37 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 33 (showing top):
chr19p13, ZWANG_DOWN_BY_2ND_EGF_PULSE, ATF6_TARGET_GENES, E2F5_TARGET_GENES, HES2_TARGET_GENES, HOXB4_TARGET_GENES, LMTK3_TARGET_GENES, MAFG_TARGET_GENES, RYBP_TARGET_GENES, SKIL_TARGET_GENES, ZFP91_TARGET_GENES, ZNF197_TARGET_GENES, ZNF22_TARGET_GENES, ZNF436_TARGET_GENES, ZNF592_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
170 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SAXO5 | ZNF783 | Q6ZMS7 | 480 |
| SAXO5 | TRAPPC5 | Q8IUR0 | 478 |
| SAXO5 | PEX11G | Q96HA9 | 470 |
| SAXO5 | MEDAG | Q5VYS4 | 451 |
| SAXO5 | KPLCE | Q5T750 | 445 |
| SAXO5 | PDAP1 | Q13442 | 431 |
| SAXO5 | BPIFB3 | P59826 | 419 |
| SAXO5 | GPATCH4 | Q5T3I0 | 413 |
| SAXO5 | B3GLCT | Q6Y288 | 393 |
| SAXO5 | ZDHHC19 | Q8WVZ1 | 377 |
| SAXO5 | PHF7 | Q9BWX1 | 353 |
| SAXO5 | GPR171 | O14626 | 328 |
| SAXO5 | NAA25 | Q14CX7 | 321 |
| SAXO5 | SPMIP9 | Q96LM6 | 321 |
| SAXO5 | HELQ | Q8TDG4 | 311 |
IntAct
18 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ARMC7 | SAXO5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP6-3 | SAXO5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYSRT1 | SAXO5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SAXO5 | NEK6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SAXO5 | ARMC7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SAXO5 | TEKT3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SAXO5 | WDR47 | psi-mi:“MI:0914”(association) | 0.350 |
| SAXO5 | KRTAP6-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SAXO5 | CYSRT1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| NEK6 | SAXO5 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TEKT3 | SAXO5 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (29): WDR47 (Affinity Capture-MS), UBR3 (Affinity Capture-MS), ANKFY1 (Affinity Capture-MS), FAM83H (Affinity Capture-MS), CADPS2 (Affinity Capture-MS), BRCA2 (Affinity Capture-MS), LONP1 (Affinity Capture-MS), KLHL23 (Affinity Capture-MS), HSPA8 (Affinity Capture-MS), PTPRD (Affinity Capture-MS), TARBP1 (Affinity Capture-MS), PPP2R2D (Affinity Capture-MS), HAPLN3 (Affinity Capture-MS), FGFR1 (Affinity Capture-MS), C19orf45 (Two-hybrid)
ESM2 similar proteins: A0A1B0GTD5, A0A1B0GTJ6, A0A1B0GUX0, A0A3Q1MT14, A0JNL1, A5PJD8, B9EJX3, E1B9R1, E1BNS6, F1MMV1, Q0P591, Q148A4, Q14BB9, Q1JPL0, Q2KJ10, Q2MH31, Q2T9T0, Q2TA11, Q32L72, Q32L77, Q3V0Q6, Q5BN46, Q5PQN4, Q5RBH3, Q5RHU7, Q5SPV6, Q5SVJ3, Q5VTT2, Q5VZQ5, Q66HR9, Q6AYM0, Q7Z5V6, Q8CDU5, Q8N5S3, Q8N865, Q8NA69, Q8NCR6, Q8NEG2, Q95LU0, Q96K30
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
14 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 4 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1503 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:7504408:A:G | donor_gain | 1.0000 |
| 19:7505535:AC:A | acceptor_gain | 1.0000 |
| 19:7505536:C:CA | acceptor_gain | 1.0000 |
| 19:7505623:CCAG:C | donor_loss | 1.0000 |
| 19:7505624:CAG:C | donor_loss | 1.0000 |
| 19:7505626:GGTG:G | donor_loss | 1.0000 |
| 19:7505627:GT:G | donor_loss | 1.0000 |
| 19:7507138:GCGG:G | donor_gain | 1.0000 |
| 19:7497636:C:G | donor_gain | 0.9900 |
| 19:7501397:TCGGT:T | donor_loss | 0.9900 |
| 19:7501400:G:A | donor_loss | 0.9900 |
| 19:7501400:G:GG | donor_gain | 0.9900 |
| 19:7501402:G:GG | donor_loss | 0.9900 |
| 19:7504118:AAG:A | acceptor_gain | 0.9900 |
| 19:7504118:AAGG:A | acceptor_gain | 0.9900 |
| 19:7504118:AAGGG:A | acceptor_gain | 0.9900 |
| 19:7504305:CCACA:C | acceptor_loss | 0.9900 |
| 19:7504306:CACA:C | acceptor_loss | 0.9900 |
| 19:7504308:CA:C | acceptor_loss | 0.9900 |
| 19:7504309:A:AG | acceptor_gain | 0.9900 |
| 19:7504310:G:GT | acceptor_gain | 0.9900 |
| 19:7504380:GCC:G | donor_gain | 0.9900 |
| 19:7504395:G:GT | donor_gain | 0.9900 |
| 19:7504407:GA:G | donor_gain | 0.9900 |
| 19:7504407:GATAG:G | donor_gain | 0.9900 |
| 19:7504408:A:AG | donor_gain | 0.9900 |
| 19:7505319:TACA:T | acceptor_loss | 0.9900 |
| 19:7505321:CA:C | acceptor_loss | 0.9900 |
| 19:7505323:G:GT | acceptor_loss | 0.9900 |
| 19:7505375:T:TA | acceptor_gain | 0.9900 |
AlphaMissense
3286 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:7504183:T:C | F214L | 0.982 |
| 19:7504185:C:A | F214L | 0.982 |
| 19:7504185:C:G | F214L | 0.982 |
| 19:7501078:T:C | F86L | 0.965 |
| 19:7501080:C:A | F86L | 0.965 |
| 19:7501080:C:G | F86L | 0.965 |
| 19:7500898:T:C | F26L | 0.964 |
| 19:7500900:C:A | F26L | 0.964 |
| 19:7500900:C:G | F26L | 0.964 |
| 19:7501276:T:C | F152L | 0.963 |
| 19:7501278:C:A | F152L | 0.963 |
| 19:7501278:C:G | F152L | 0.963 |
| 19:7506057:T:C | F367L | 0.963 |
| 19:7506059:C:A | F367L | 0.963 |
| 19:7506059:C:G | F367L | 0.963 |
| 19:7508275:T:C | F455L | 0.962 |
| 19:7508277:T:A | F455L | 0.962 |
| 19:7508277:T:G | F455L | 0.962 |
| 19:7500961:T:C | F47L | 0.959 |
| 19:7500963:T:A | F47L | 0.959 |
| 19:7500963:T:G | F47L | 0.959 |
| 19:7501348:T:C | F176L | 0.948 |
| 19:7501350:T:A | F176L | 0.948 |
| 19:7501350:T:G | F176L | 0.948 |
| 19:7505559:T:C | I313T | 0.941 |
| 19:7500880:T:C | F20L | 0.938 |
| 19:7500882:C:A | F20L | 0.938 |
| 19:7500882:C:G | F20L | 0.938 |
| 19:7505388:T:C | F283L | 0.927 |
| 19:7505390:C:A | F283L | 0.927 |
dbSNP variants (sampled 300 via entrez): RS1000103707 (19:7499189 G>A), RS1000485092 (19:7505908 C>A,G,T), RS1000545164 (19:7499960 G>A), RS1000638630 (19:7500332 C>T), RS1000836036 (19:7505553 C>G,T), RS1000991271 (19:7503391 G>T), RS1001642006 (19:7498820 A>G), RS1002231743 (19:7508701 A>T), RS1002494632 (19:7503106 T>C), RS1002509839 (19:7497200 T>A), RS1003284031 (19:7507672 C>G), RS1003298717 (19:7507906 A>G), RS1003320903 (19:7507435 TAGTC>T), RS1003395696 (19:7501543 C>G,T), RS1003513619 (19:7496354 G>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
20 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010796_3101 | Electrocardiogram morphology (amplitude at temporal datapoints) | 1.000000e-09 |
| GCST010796_3102 | Electrocardiogram morphology (amplitude at temporal datapoints) | 8.000000e-11 |
| GCST010796_3103 | Electrocardiogram morphology (amplitude at temporal datapoints) | 3.000000e-10 |
| GCST010796_3104 | Electrocardiogram morphology (amplitude at temporal datapoints) | 3.000000e-09 |
| GCST010796_3105 | Electrocardiogram morphology (amplitude at temporal datapoints) | 6.000000e-09 |
| GCST010796_3106 | Electrocardiogram morphology (amplitude at temporal datapoints) | 4.000000e-08 |
| GCST010796_3107 | Electrocardiogram morphology (amplitude at temporal datapoints) | 3.000000e-09 |
| GCST010796_3108 | Electrocardiogram morphology (amplitude at temporal datapoints) | 2.000000e-09 |
| GCST010796_3109 | Electrocardiogram morphology (amplitude at temporal datapoints) | 7.000000e-11 |
| GCST010796_3110 | Electrocardiogram morphology (amplitude at temporal datapoints) | 2.000000e-08 |
| GCST010796_3111 | Electrocardiogram morphology (amplitude at temporal datapoints) | 2.000000e-08 |
| GCST010796_3112 | Electrocardiogram morphology (amplitude at temporal datapoints) | 8.000000e-09 |
| GCST010796_3113 | Electrocardiogram morphology (amplitude at temporal datapoints) | 3.000000e-08 |
| GCST010796_3744 | Electrocardiogram morphology (amplitude at temporal datapoints) | 2.000000e-13 |
| GCST010796_3745 | Electrocardiogram morphology (amplitude at temporal datapoints) | 1.000000e-10 |
| GCST010796_3746 | Electrocardiogram morphology (amplitude at temporal datapoints) | 2.000000e-10 |
| GCST010796_3747 | Electrocardiogram morphology (amplitude at temporal datapoints) | 4.000000e-08 |
| GCST010796_3748 | Electrocardiogram morphology (amplitude at temporal datapoints) | 3.000000e-10 |
| GCST010796_3749 | Electrocardiogram morphology (amplitude at temporal datapoints) | 6.000000e-12 |
| GCST010796_3750 | Electrocardiogram morphology (amplitude at temporal datapoints) | 1.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004327 | electrocardiography |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sotorasib | affects cotreatment, decreases expression | 1 |
| bisphenol S | increases methylation | 1 |
| trametinib | affects cotreatment, decreases expression | 1 |
| NVP-BKM120 | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Niclosamide | increases expression | 1 |
| Phthalic Acids | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.